Open Collections

UBC Faculty Research and Publications

Is newer better? New drugs for treatment of overactive bladder Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 66 provides an update on the prescription drug treatments for overactive bladder that were previously reviewed in Therapeutics Letter 57. The current Letter summarizes the Common Drug Review (CDR) reports on three drugs newly available in Canada for the treatment of overactive bladder (darifenacin, solifenacin and trospium). Conclusions: Based on the CDR systematic reviews, the three new drugs to treat overactive bladder syndrome are more expensive than oxybutynin with little or no therapeutic advantage in efficacy or adverse effects.

Item Metadata

Title
Is newer better? New drugs for treatment of overactive bladder
Alternate Title
Therapeutics Letter 66
Creator
Therapeutics Initiative (University of British Columbia)
Date Issued
2007-10
Description
Therapeutics Letter 66 provides an update on the prescription drug treatments for overactive bladder that were previously reviewed in Therapeutics Letter 57. The current Letter summarizes the Common Drug Review (CDR) reports on three drugs newly available in Canada for the treatment of overactive bladder (darifenacin, solifenacin and trospium). Conclusions: Based on the CDR systematic reviews, the three new drugs to treat overactive bladder syndrome are more expensive than oxybutynin with little or no therapeutic advantage in efficacy or adverse effects.
Subject
Darifenacin; Muscarinic Antagonists; Oxybutynin; Solifenacin Succinate; Urinary Bladder, Overactive
Genre
Other
Type
Text
Language
eng
Notes
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
Date Available
2023-06-20
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
DOI
10.14288/1.0433645
URI
http://hdl.handle.net/2429/85055
Affiliation
Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of
Peer Review Status
Reviewed
Scholarly Level
Faculty; Researcher
Rights URI
http://creativecommons.org/licenses/by-nc-nd/4.0/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International